المؤلفون: De Kretser D.M., Robertson D.M., Frydenberg M., Balourdos G., Stanton P.G., O'Donnell L., McLachlan R.I.

مصطلحات الفهرس: medroxyprogesterone acetate/cb [Drug Combination], medroxyprogesterone acetate/do [Drug Dose], medroxyprogesterone acetate/dt [Drug Therapy], medroxyprogesterone acetate/pd [Pharmacology], testosterone/cb [Drug Combination], testosterone/do [Drug Dose], testosterone/dt [Drug Therapy], testosterone/pd [Pharmacology], priority journal, adult, article, azoospermia/dt [Drug Therapy], cell population, clinical article, enzyme activity, epithelium cell, germ cell, hormonal contraception, human, male, male fertility, receptor upregulation, reproduction, semen analysis, spermatogenesis, spermatozoon count, spermatozoon maturation, inhibin, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33096
Click here for full text options
LibKey Link

المؤلفون: Johns K.R., Littlejohn G.O., Craven R.L.

مصطلحات الفهرس: rheumatic disease/dt [Drug Therapy], systemic lupus erythematosus/dt [Drug Therapy], thrombosis/si [Side Effect], azathioprine/dt [Drug Therapy], conjugated estrogen/ad [Drug Administration], conjugated estrogen/cb [Drug Combination], conjugated estrogen/do [Drug Dose], conjugated estrogen/pr [Pharmaceutics], corticosteroid/do [Drug Dose], corticosteroid/dt [Drug Therapy], cyproterone acetate plus estradiol valerate/ad [Drug Administration], cyproterone acetate plus estradiol valerate/do [Drug Dose], cyproterone acetate plus estradiol valerate/pr [Pharmaceutics], desogestrel plus ethinylestradiol/ad [Drug Administration], desogestrel plus ethinylestradiol/do [Drug Dose], desogestrel plus ethinylestradiol/pr [Pharmaceutics], diane/ad [Drug Administration], diane/do [Drug Dose], diane/pr [Pharmaceutics], estradiol/ad [Drug Administration], estradiol/cb [Drug Combination], estradiol/do [Drug Dose], estradiol/pr [Pharmaceutics], estradiol plus norethisterone acetate/ad [Drug Administration], estradiol plus norethisterone acetate/do [Drug Dose], estradiol plus norethisterone acetate/pr [Pharmaceutics], ethinylestradiol plus gestodene/ad [Drug Administration], ethinylestradiol plus gestodene/do [Drug Dose], ethinylestradiol plus gestodene/pr [Pharmaceutics], ethinylestradiol plus norethisterone, hydroxychloroquine/do [Drug Dose], hydroxychloroquine/dt [Drug Therapy], medroxyprogesterone acetate/ad [Drug Administration], medroxyprogesterone acetate/cb [Drug Combination], medroxyprogesterone acetate/do [Drug Dose], medroxyprogesterone acetate/pr [Pharmaceutics], oral contraceptive agent/ae [Adverse Drug Reaction], oral contraceptive agent/ad [Drug Administration], oral contraceptive agent/pr [Pharmaceutics], prednisolone/do [Drug Dose], prednisolone/dt [Drug Therapy], trisequens/ad [Drug Administration], trisequens/do [Drug Dose], trisequens/pr [Pharmaceutics], unclassified drug, improvil, monofeme, panafcortelone, trifeme, oral contraceptive agent/do [Drug Dose], ethinylestradiol plus levonorgestrel/ad [Drug Administration], ethinylestradiol plus levonorgestrel/do [Drug Dose], ethinylestradiol plus levonorgestrel/pr [Pharmaceutics], atherosclerosis/si [Side Effect], female, fibromyalgia/dt [Drug Therapy], gout/dt [Drug Therapy], hormone substitution, human, oral contraception, oral drug administration, osteoarthritis/dt [Drug Therapy], osteoporosis/si [Side Effect], pregnancy, review, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33965
Click here for full text options
LibKey Link

المؤلفون: De Kretser D.M., Robertson D.M., Frydenberg M., Balourdos G., Stanton P.G., O'Donnell L., McLachlan R.I.

مصطلحات الفهرس: medroxyprogesterone acetate/cb [Drug Combination], medroxyprogesterone acetate/do [Drug Dose], medroxyprogesterone acetate/dt [Drug Therapy], medroxyprogesterone acetate/pd [Pharmacology], testosterone/cb [Drug Combination], testosterone/do [Drug Dose], testosterone/dt [Drug Therapy], testosterone/pd [Pharmacology], priority journal, adult, article, azoospermia/dt [Drug Therapy], cell population, clinical article, enzyme activity, epithelium cell, germ cell, hormonal contraception, human, male, male fertility, receptor upregulation, reproduction, semen analysis, spermatogenesis, spermatozoon count, spermatozoon maturation, inhibin, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33096
LibKey Link

المؤلفون: Johns K.R., Littlejohn G.O., Craven R.L.

مصطلحات الفهرس: rheumatic disease/dt [Drug Therapy], systemic lupus erythematosus/dt [Drug Therapy], thrombosis/si [Side Effect], azathioprine/dt [Drug Therapy], conjugated estrogen/ad [Drug Administration], conjugated estrogen/cb [Drug Combination], conjugated estrogen/do [Drug Dose], conjugated estrogen/pr [Pharmaceutics], corticosteroid/do [Drug Dose], corticosteroid/dt [Drug Therapy], cyproterone acetate plus estradiol valerate/ad [Drug Administration], cyproterone acetate plus estradiol valerate/do [Drug Dose], cyproterone acetate plus estradiol valerate/pr [Pharmaceutics], desogestrel plus ethinylestradiol/ad [Drug Administration], desogestrel plus ethinylestradiol/do [Drug Dose], desogestrel plus ethinylestradiol/pr [Pharmaceutics], diane/ad [Drug Administration], diane/do [Drug Dose], diane/pr [Pharmaceutics], estradiol/ad [Drug Administration], estradiol/cb [Drug Combination], estradiol/do [Drug Dose], estradiol/pr [Pharmaceutics], estradiol plus norethisterone acetate/ad [Drug Administration], estradiol plus norethisterone acetate/do [Drug Dose], estradiol plus norethisterone acetate/pr [Pharmaceutics], ethinylestradiol plus gestodene/ad [Drug Administration], ethinylestradiol plus gestodene/do [Drug Dose], ethinylestradiol plus gestodene/pr [Pharmaceutics], ethinylestradiol plus norethisterone, hydroxychloroquine/do [Drug Dose], hydroxychloroquine/dt [Drug Therapy], medroxyprogesterone acetate/ad [Drug Administration], medroxyprogesterone acetate/cb [Drug Combination], medroxyprogesterone acetate/do [Drug Dose], medroxyprogesterone acetate/pr [Pharmaceutics], oral contraceptive agent/ae [Adverse Drug Reaction], oral contraceptive agent/ad [Drug Administration], oral contraceptive agent/pr [Pharmaceutics], prednisolone/do [Drug Dose], prednisolone/dt [Drug Therapy], trisequens/ad [Drug Administration], trisequens/do [Drug Dose], trisequens/pr [Pharmaceutics], unclassified drug, improvil, monofeme, panafcortelone, trifeme, oral contraceptive agent/do [Drug Dose], ethinylestradiol plus levonorgestrel/ad [Drug Administration], ethinylestradiol plus levonorgestrel/do [Drug Dose], ethinylestradiol plus levonorgestrel/pr [Pharmaceutics], atherosclerosis/si [Side Effect], female, fibromyalgia/dt [Drug Therapy], gout/dt [Drug Therapy], hormone substitution, human, oral contraception, oral drug administration, osteoarthritis/dt [Drug Therapy], osteoporosis/si [Side Effect], pregnancy, review, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33965
LibKey Link

المؤلفون: Robertson D.M., Burger H.G., McLachlan R.I., Matthiesson K.L.

مصطلحات الفهرس: drug blood level, drug effect, germ cell, gynecomastia/si [Side Effect], hormonal contraception, hormonal regulation, hormone response, human, human experiment, injection, male, normal human, protein blood level, randomized controlled trial, single drug dose, spermatogenesis, spermatozoon count, biological marker/ec [Endogenous Compound], chorionic gonadotropin/ae [Adverse Drug Reaction], chorionic gonadotropin/ct [Clinical Trial], chorionic gonadotropin/cb [Drug Combination], chorionic gonadotropin/cm [Drug Comparison], chorionic gonadotropin/cr [Drug Concentration], chorionic gonadotropin/do [Drug Dose], chorionic gonadotropin/pd [Pharmacology], chorionic gonadotropin/sc [Subcutaneous Drug Administration], gestagen/ct [Clinical Trial], gestagen/cb [Drug Combination], gestagen/pd [Pharmacology], inhibin B/ec [Endogenous Compound], medroxyprogesterone acetate/ct [Clinical Trial], recombinant follitropin/do [Drug Dose], recombinant follitropin/pd [Pharmacology], recombinant follitropin/sc [Subcutaneous Drug Administration], steroid hormone/ct [Clinical Trial], steroid hormone/cb [Drug Combination], steroid hormone/cr [Drug Concentration], steroid hormone/dl [Intradermal Drug Administration], steroid hormone/pd [Pharmacology], testosterone/cb [Drug Combination], testosterone/cr [Drug Concentration], testosterone/dl [Intradermal Drug Administration], testosterone/pd [Pharmacology], testosterone ester/ct [Clinical Trial], testosterone/ct [Clinical Trial], medroxyprogesterone acetate/cb [Drug Combination], medroxyprogesterone acetate/do [Drug Dose], medroxyprogesterone acetate/im [Intramuscular Drug Administration], medroxyprogesterone acetate/pd [Pharmacology], protein subunit/ec [Endogenous Compound], recombinant follitropin/ae [Adverse Drug Reaction], recombinant follitropin/ct [Clinical Trial], recombinant follitropin/cb [Drug Combination], recombinant follitropin/cm [Drug Comparison], recombinant follitropin/cr [Drug Concentration], adult, article, clinical trial, controlled clinical trial, controlled study, dose time effect relation, Article

URL: Human Reproduction
Click here for full text options
LibKey Link

المؤلفون: Robertson D.M., Burger H.G., McLachlan R.I., Matthiesson K.L.

مصطلحات الفهرس: drug blood level, drug effect, germ cell, gynecomastia/si [Side Effect], hormonal contraception, hormonal regulation, hormone response, human, human experiment, injection, male, normal human, protein blood level, randomized controlled trial, single drug dose, spermatogenesis, spermatozoon count, biological marker/ec [Endogenous Compound], chorionic gonadotropin/ae [Adverse Drug Reaction], chorionic gonadotropin/ct [Clinical Trial], chorionic gonadotropin/cb [Drug Combination], chorionic gonadotropin/cm [Drug Comparison], chorionic gonadotropin/cr [Drug Concentration], chorionic gonadotropin/do [Drug Dose], chorionic gonadotropin/pd [Pharmacology], chorionic gonadotropin/sc [Subcutaneous Drug Administration], gestagen/ct [Clinical Trial], gestagen/cb [Drug Combination], gestagen/pd [Pharmacology], inhibin B/ec [Endogenous Compound], medroxyprogesterone acetate/ct [Clinical Trial], recombinant follitropin/do [Drug Dose], recombinant follitropin/pd [Pharmacology], recombinant follitropin/sc [Subcutaneous Drug Administration], steroid hormone/ct [Clinical Trial], steroid hormone/cb [Drug Combination], steroid hormone/cr [Drug Concentration], steroid hormone/dl [Intradermal Drug Administration], steroid hormone/pd [Pharmacology], testosterone/cb [Drug Combination], testosterone/cr [Drug Concentration], testosterone/dl [Intradermal Drug Administration], testosterone/pd [Pharmacology], testosterone ester/ct [Clinical Trial], testosterone/ct [Clinical Trial], medroxyprogesterone acetate/cb [Drug Combination], medroxyprogesterone acetate/do [Drug Dose], medroxyprogesterone acetate/im [Intramuscular Drug Administration], medroxyprogesterone acetate/pd [Pharmacology], protein subunit/ec [Endogenous Compound], recombinant follitropin/ae [Adverse Drug Reaction], recombinant follitropin/ct [Clinical Trial], recombinant follitropin/cb [Drug Combination], recombinant follitropin/cm [Drug Comparison], recombinant follitropin/cr [Drug Concentration], adult, article, clinical trial, controlled clinical trial, controlled study, dose time effect relation, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32471
Human Reproduction
LibKey Link